Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume $0.51 +0.08 (+18.79%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acurx Pharmaceuticals Short Interest DataAcurx Pharmaceuticals (ACXP) has a short interest of 527,300 shares, representing 2.59% of the float (the number of shares available for trading by the public). This marks a 78.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.65 million shares to cover all short positions.Current Short Interest527,300 sharesPrevious Short Interest295,500 sharesChange Vs. Previous Month+78.44%Dollar Volume Sold Short$160.83 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares23,480,000 sharesFloat Size20,390,000 sharesShort Percent of Float2.59%Today's Trading Volume2,269,241 sharesAverage Trading Volume1,654,370 sharesToday's Volume Vs. Average137% Short Selling Acurx Pharmaceuticals? Sign up to receive the latest short interest report for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACXP Short Interest Over TimeACXP Days to Cover Over TimeACXP Percentage of Float Shorted Over Time Acurx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025527,300 shares $160.83 thousand +78.4%2.6%0.1 $0.31 5/31/2025295,500 shares $112.97 thousand -23.0%1.5%1.6 $0.38 5/15/2025383,600 shares $143.12 thousand +8.7%1.9%1.5 $0.37 4/30/2025353,000 shares $151.79 thousand -15.7%1.8%1.5 $0.43 4/15/2025418,900 shares $159.18 thousand -11.9%2.2%1.7 $0.38 3/31/2025475,600 shares $185.48 thousand +12.2%2.5%1.3 $0.39 3/15/2025423,800 shares $195.37 thousand -6.4%2.2%1.2 $0.46 2/28/2025452,800 shares $321.26 thousand +112.2%2.7%1.3 $0.71 2/15/2025213,400 shares $158.34 thousand -31.8%1.3%0.6 $0.74 1/31/2025313,100 shares $228.75 thousand -52.2%1.9%1.2 $0.73 Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025655,000 shares $471.53 thousand +41.9%4.0%2.5 $0.72 12/31/2024461,600 shares $375.74 thousand -8.1%2.8%2.2 $0.81 12/15/2024502,100 shares $429.35 thousand +8.2%3.5%4 $0.86 11/30/2024463,900 shares $579.88 thousand +4.6%3.2%4.1 $1.25 11/15/2024443,700 shares $763.16 thousand -6.5%3.1%5.9 $1.72 10/31/2024474,500 shares $892.06 thousand -5.5%3.4%10.1 $1.88 10/15/2024501,900 shares $1.02 million +2.1%3.6%10.2 $2.04 9/30/2024491,700 shares $934.23 thousand +2.8%3.6%7.6 $1.90 9/15/2024478,300 shares $975.73 thousand +5.6%3.5%7.8 $2.04 8/31/2024452,800 shares $996.16 thousand +3.1%3.3%7.7 $2.20 8/15/2024439,400 shares $896.38 thousand -5.4%3.2%8.1 $2.04 7/31/2024464,300 shares $1.00 million -17.3%3.5%7.8 $2.16 7/15/2024561,200 shares $1.34 million -8.6%4.2%9.4 $2.39 6/30/2024614,100 shares $1.38 million -7.1%4.6%10.9 $2.25 6/15/2024661,200 shares $1.61 million -4.0%4.9%10.6 $2.43 5/31/2024688,400 shares $1.73 million +15.6%5.1%9.2 $2.51 5/15/2024595,600 shares $1.34 million -3.2%4.4%7.4 $2.25 4/30/2024615,500 shares $1.38 million +6.3%4.7%7.4 $2.25 4/15/2024579,100 shares $946.83 thousand +71.6%4.8%5.6 $1.64 3/31/2024337,400 shares $826.63 thousand +14.6%2.8%2 $2.45 3/15/2024294,500 shares $801.04 thousand +0.9%2.5%1.7 $2.72 2/29/2024291,900 shares $837.75 thousand -3.2%2.6%1.3 $2.87 2/15/2024301,500 shares $919.58 thousand -12.3%2.7%1.3 $3.05 1/31/2024343,700 shares $1.12 million +41.1%3.0%1.4 $3.27 1/15/2024243,600 shares $1.13 million -18.5%2.1%0.7 $4.63 12/31/2023298,800 shares $1.14 million -32.0%2.6%0.5 $3.83 12/15/2023439,100 shares $1.54 million -21.0%3.9%0.5 $3.50 11/30/2023555,800 shares $1.96 million -14.3%5.0%0.7 $3.52 11/15/2023648,300 shares $2.23 million -31.5%5.8%0.9 $3.44 10/31/2023946,100 shares $5.06 million -9.0%9.0%1.3 $5.35Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 10/15/20231,040,000 shares $4.51 million +10,197.0%9.9%1.6 $4.34 9/30/202310,100 shares $15.15 thousand +50.8%0.1%0 $1.50 9/15/20236,700 shares $11.86 thousand -51.1%0.1%0.2 $1.77 8/31/202313,700 shares $26.44 thousand +95.7%0.1%0.4 $1.93 8/15/20237,000 shares $11.20 thousand -63.0%0.1%0.2 $1.60 7/31/202318,900 shares $38.37 thousand +42.1%0.2%0.7 $2.03 7/15/202313,300 shares $28.46 thousand +58.3%0.1%0.5 $2.14 6/30/20238,400 shares $22.26 thousand -27.6%0.1%0.3 $2.65 6/15/202311,600 shares $31.90 thousand +39.8%0.1%0.5 $2.75 5/31/20238,300 shares $25.73 thousand -60.9%0.1%0.3 $3.10 5/15/202321,200 shares $71.87 thousand -7.0%0.2%0.7 $3.39 4/30/202322,800 shares $68.17 thousand +4.1%0.3%0.7 $2.99 4/15/202321,900 shares $64.82 thousand -25.5%0.2%0.7 $2.96 3/31/202329,400 shares $101.72 thousand -52.8%0.3%0.9 $3.46 3/15/202362,300 shares $212.44 thousand +150.2%0.7%1.8 $3.41 2/28/202324,900 shares $82.42 thousand -33.8%0.3%0.7 $3.31 2/15/202337,600 shares $131.98 thousand +78.2%0.4%1.2 $3.51 1/31/202321,100 shares $75.96 thousand -7.9%0.2%0.7 $3.60 1/15/202322,900 shares $97.33 thousand -3.4%0.2%0.9 $4.25 12/30/202223,700 shares $94.33 thousand -18.0%0.3%1 $3.98 12/15/202228,900 shares $112.71 thousand +26.8%0.3%1.4 $3.90 11/30/202222,800 shares $72.73 thousand -1.3%0.2%1 $3.19 11/15/202223,100 shares $72.07 thousand +5.5%0.3%1 $3.12 10/31/202221,900 shares $67.45 thousand -27.2%0.2%0.8 $3.08 10/15/202230,100 shares $88.80 thousand -22.2%0.3%1.1 $2.95 9/30/202238,700 shares $116.10 thousand +45.5%0.4%1.5 $3.00 9/15/202226,600 shares $103.74 thousand +10.8%0.3%1 $3.90 8/31/202224,000 shares $83.76 thousand -34.1%0.3%0.9 $3.49 8/15/202236,400 shares $164.16 thousand -13.5%0.4%1.6 $4.51 7/31/202242,100 shares $150.72 thousand +89.6%0.5%2.1 $3.58 7/15/202222,200 shares $80.48 thousand -43.9%N/A1.4 $3.63 6/30/202239,600 shares $150.08 thousand -29.9%N/A2.5 $3.79 6/15/202256,500 shares $213.57 thousand +16.3%N/A3.2 $3.78 5/31/202248,600 shares $130.73 thousand -1.2%N/A2.8 $2.69 5/15/202249,200 shares $133.33 thousand +39.4%N/A2.7 $2.71 4/30/202235,300 shares $131.67 thousand -59.2%N/A2 $3.73 4/15/202286,600 shares $346.40 thousand -22.3%N/A3.3 $4.00 3/31/2022111,400 shares $365.39 thousand +136.5%N/A4 $3.28 3/15/202247,100 shares $175.68 thousand +9.0%N/A1.6 $3.73 2/28/202243,200 shares $157.21 thousand -53.7%N/A1.4 $3.64 2/15/202293,300 shares $376.00 thousand -4.3%N/A2.6 $4.03 1/31/202297,500 shares $405.60 thousand -28.8%N/A2.3 $4.16 1/15/2022137,000 shares $627.46 thousand -16.2%N/A3 $4.58 12/31/2021163,400 shares $706.12 thousand -6.0%N/A3.6 $4.32 12/15/2021173,800 shares $716.06 thousand +52.2%N/A2.9 $4.12 11/30/2021114,200 shares $548.16 thousand -17.1%N/A1.9 $4.80 11/15/2021137,700 shares $684.37 thousand +14.9%N/A2.2 $4.97 10/29/2021119,800 shares $599 thousand +17.7%N/A1.7 $5.00 10/15/2021101,800 shares $499.84 thousand -4.9%N/A1.2 $4.91 9/30/2021107,000 shares $549.98 thousand +11.2%N/A0.8 $5.14Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 9/15/202196,200 shares $485.81 thousand +24.9%N/A0.2 $5.05 8/31/202177,000 shares $398.09 thousand -35.9%N/A0.1 $5.17 8/13/2021120,100 shares $576.48 thousand No ChangeN/A0.1 $4.80 ACXP Short Interest - Frequently Asked Questions What is Acurx Pharmaceuticals' current short interest? Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 527,300 shares of ACXP short. 2.59% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest. What is a good short interest percentage for Acurx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.59% of Acurx Pharmaceuticals' floating shares are currently sold short. Is Acurx Pharmaceuticals' short interest increasing or decreasing? Acurx Pharmaceuticals saw a increase in short interest in June. As of June 15th, there was short interest totaling 527,300 shares, an increase of 78.4% from the previous total of 295,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acurx Pharmaceuticals' float size? Acurx Pharmaceuticals currently has issued a total of 23,480,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 20,390,000 shares. How does Acurx Pharmaceuticals' short interest compare to its competitors? 2.59% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Acurx Pharmaceuticals: Aadi Bioscience, Inc. (6.58%), Context Therapeutics Inc. (2.98%), Annovis Bio, Inc. (14.32%), RenovoRx, Inc. (0.39%), Avalo Therapeutics, Inc. (0.97%), Century Therapeutics, Inc. (5.71%), vTv Therapeutics Inc. (1.21%), bluebird bio, Inc. (2.91%), Prelude Therapeutics Incorporated (3.45%), Applied Therapeutics Inc. (15.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Acurx Pharmaceuticals stock? Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acurx Pharmaceuticals? A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further. How often is Acurx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Aadi Bioscience Short Interest Context Therapeutics Short Interest Annovis Bio Short Interest RenovoRx Short Interest Avalo Therapeutics Short Interest Century Therapeutics Short Interest vTv Therapeutics Short Interest bluebird bio Short Interest Prelude Therapeutics Short Interest Applied Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACXP) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
